Alprazolam: Difference between revisions
From SEHK Wiki
No edit summary |
|||
| Line 32: | Line 32: | ||
{| class="wikitable" | {| class="wikitable" | ||
!Short-term use in anxiety | !style="text-align: left"| Short-term use in anxiety | ||
|By mouth | |By mouth | ||
*ADULT: 250 – 500 micrograms 3 times a day, increased if necessary, every 3 to 4 days, up to 3 mg daily. | *ADULT: 250 – 500 micrograms 3 times a day, increased if necessary, every 3 to 4 days, up to 3 mg daily. | ||
*ELDERLY: 250 micrograms 2 – 3 times a day | *ELDERLY: 250 micrograms 2 – 3 times a day | ||
*DEBILITATED PATIENTS: 250 micrograms 2 – 3 times a day | *DEBILITATED PATIENTS: 250 micrograms 2 – 3 times a day | ||
Revision as of 01:27, 6 October 2020
Introduction
Alprazolam is a short-acting benzodiazepine. It is used in the short-term treatment of anxiety disorders, specifically panic disorder or generalized anxiety disorder (GAD). GAD improvement occurs generally within a week. Alprazolam is generally taken by mouth.
Pronunciation
Alprazolam 0.25mg (XANAX)
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Alprazolam Tablet 0.25 mg | ALPR01 | DDA |
| Alprazolam Tablet 0.5 mg | ALPR02 | DDA |
Mechanism of Action
- Alprazolam is a benzodiazepine.
- Gama-Aminobutyric acid (GABA) is an inhibitory neurotransmitter, acting on the GABA receptors in the central nervous system (CNS), thus inhibiting the nerve impulses.
- Alprazolam acts on the benzodiazepine receptors in the brain and the spinal cord. Benzodiazepine receptors in the CNS are linked with GABA receptors as a complex.
- Alprazolam by binding to the benzodiazepine receptors results in activation of the GABA-benzodiazepine receptor complex, resulting in inhibition of nerve impulses, overall depression of brain and spinal cord.
- Thus alprazolam use helps to promote muscle relaxation, reduce anxiety, control of convulsions and promote sleep.
Dosage
| Short-term use in anxiety | By mouth
|
|---|
